A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer

NCT02127151 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Withdrawal of Industry support for the study

Conditions

Interventions

Sponsor

University College, London

Collaborators